Medtronic PLC Asset Resilience Ratio
Medtronic PLC asset resilience ratio. Medtronic PLC (2M6) has an Asset Resilience Ratio of 7.82% as of April 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Medtronic PLC carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Medtronic PLC (2000–2026)
Asset resilience ratio of Medtronic PLC from 2000 to 2026. This chart shows how Medtronic PLC's Asset Resilience Ratio has changed over time. See Medtronic PLC (2M6) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Medtronic PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 2M6 current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €7.27 Billion | 7.82% |
| Total Liquid Assets | €7.27 Billion | 7.82% |
Asset Resilience Insights
- Limited Liquidity: Medtronic PLC maintains only 7.82% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Medtronic PLC Industry Peers by Asset Resilience Ratio
Compare Medtronic PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
Medtronic PLC Asset Resilience Ratio by Year (2000–2026)
Medtronic PLC asset resilience ratio by year from 2000 to 2026. The table below shows the annual Asset Resilience Ratio data for Medtronic PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2026-04-30 | 7.82% | €7.27 Billion ≈ $8.50 Billion |
€93.03 Billion ≈ $108.76 Billion |
+0.46pp |
| 2025-04-30 | 7.36% | €6.75 Billion ≈ $7.89 Billion |
€91.68 Billion ≈ $107.18 Billion |
-0.11pp |
| 2024-04-30 | 7.47% | €6.72 Billion ≈ $7.86 Billion |
€89.98 Billion ≈ $105.20 Billion |
+0.41pp |
| 2023-04-30 | 7.05% | €6.42 Billion ≈ $7.50 Billion |
€90.95 Billion ≈ $106.33 Billion |
-0.48pp |
| 2022-04-30 | 7.54% | €6.86 Billion ≈ $8.02 Billion |
€90.98 Billion ≈ $106.37 Billion |
-0.22pp |
| 2021-04-30 | 7.76% | €7.22 Billion ≈ $8.45 Billion |
€93.08 Billion ≈ $108.82 Billion |
+0.25pp |
| 2020-04-30 | 7.51% | €6.81 Billion ≈ $7.96 Billion |
€90.69 Billion ≈ $106.02 Billion |
+1.43pp |
| 2019-04-30 | 6.08% | €5.46 Billion ≈ $6.38 Billion |
€89.69 Billion ≈ $104.86 Billion |
-2.19pp |
| 2018-04-30 | 8.27% | €7.56 Billion ≈ $8.84 Billion |
€91.39 Billion ≈ $106.85 Billion |
-0.49pp |
| 2017-04-30 | 8.76% | €8.74 Billion ≈ $10.22 Billion |
€99.82 Billion ≈ $116.70 Billion |
-1.05pp |
| 2016-04-30 | 9.80% | €9.76 Billion ≈ $11.41 Billion |
€99.55 Billion ≈ $116.38 Billion |
-3.92pp |
| 2015-04-30 | 13.72% | €14.64 Billion ≈ $17.11 Billion |
€106.69 Billion ≈ $124.73 Billion |
-20.12pp |
| 2014-04-30 | 33.83% | €12.84 Billion ≈ $15.01 Billion |
€37.94 Billion ≈ $44.36 Billion |
+4.84pp |
| 2013-04-30 | 28.99% | €10.09 Billion ≈ $11.79 Billion |
€34.79 Billion ≈ $40.68 Billion |
+24.93pp |
| 2012-04-30 | 4.06% | €1.34 Billion ≈ $1.57 Billion |
€33.08 Billion ≈ $38.68 Billion |
+0.62pp |
| 2011-04-30 | 3.44% | €1.05 Billion ≈ $1.22 Billion |
€30.42 Billion ≈ $35.57 Billion |
-5.02pp |
| 2010-04-30 | 8.45% | €2.38 Billion ≈ $2.78 Billion |
€28.09 Billion ≈ $32.84 Billion |
+6.74pp |
| 2009-04-30 | 1.71% | €405.00 Million ≈ $473.49 Million |
€23.66 Billion ≈ $27.66 Billion |
-0.78pp |
| 2008-04-30 | 2.49% | €553.00 Million ≈ $646.52 Million |
€22.20 Billion ≈ $25.95 Billion |
-6.85pp |
| 2007-04-30 | 9.34% | €1.82 Billion ≈ $2.13 Billion |
€19.51 Billion ≈ $22.81 Billion |
-6.46pp |
| 2006-04-30 | 15.80% | €3.11 Billion ≈ $3.63 Billion |
€19.66 Billion ≈ $22.99 Billion |
+8.82pp |
| 2005-04-30 | 6.98% | €1.16 Billion ≈ $1.36 Billion |
€16.62 Billion ≈ $19.43 Billion |
+4.61pp |
| 2004-04-30 | 2.37% | €333.80 Million ≈ $390.25 Million |
€14.11 Billion ≈ $16.50 Billion |
+2.18pp |
| 2003-04-30 | 0.18% | €22.70 Million ≈ $26.54 Million |
€12.32 Billion ≈ $14.40 Billion |
-0.94pp |
| 2002-04-30 | 1.13% | €123.00 Million ≈ $143.80 Million |
€10.90 Billion ≈ $12.75 Billion |
-1.73pp |
| 2001-04-30 | 2.86% | €201.40 Million ≈ $235.46 Million |
€7.04 Billion ≈ $8.23 Billion |
+0.93pp |
| 2000-04-30 | 1.93% | €109.70 Million ≈ $128.25 Million |
€5.67 Billion ≈ $6.63 Billion |
-- |
About Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor sy… Read more